现代肿瘤医学
現代腫瘤醫學
현대종류의학
JOURNAL OF MODERN ONCOLOGY
2015年
13期
1905-1907
,共3页
朴冰%何伟%孙文兰%崔英%王丽梅
樸冰%何偉%孫文蘭%崔英%王麗梅
박빙%하위%손문란%최영%왕려매
基底细胞癌%手术%5-氨基酮戊酸光动力疗法%疗效
基底細胞癌%手術%5-氨基酮戊痠光動力療法%療效
기저세포암%수술%5-안기동무산광동력요법%료효
basal cell carcinoma%surgery%5-aminolevulinic acid-Photodynamic theraPy( ALA-PDT)%efficacy
目的:分析手术联合5-氨基酮戊酸光动力疗法( ALA-PDT)治疗皮肤基底细胞癌的临床疗效。方法:皮肤基底细胞癌患者30例,按抛硬币法分为观察组和对照组,每组15例。观察组患者于术前开始进行ALA-PDT治疗,每周1次,共3-7次,然后进行手术治疗,对照组患者只采取手术切除,随访16-25个月。比较两组治疗一期愈合率、有效率,并评价疗效。结果:观察组患者总有效率为100%(15/15),对照组总有效率为86.7%(13/15),差异无统计学意义(P>0.05)。两组治疗一期愈合率、不良反应率差异具有统计学意义(P<0.05),观察组优于对照组。结论:手术联合ALA-PDT治疗皮肤基底细胞癌具有有效、安全等优点。
目的:分析手術聯閤5-氨基酮戊痠光動力療法( ALA-PDT)治療皮膚基底細胞癌的臨床療效。方法:皮膚基底細胞癌患者30例,按拋硬幣法分為觀察組和對照組,每組15例。觀察組患者于術前開始進行ALA-PDT治療,每週1次,共3-7次,然後進行手術治療,對照組患者隻採取手術切除,隨訪16-25箇月。比較兩組治療一期愈閤率、有效率,併評價療效。結果:觀察組患者總有效率為100%(15/15),對照組總有效率為86.7%(13/15),差異無統計學意義(P>0.05)。兩組治療一期愈閤率、不良反應率差異具有統計學意義(P<0.05),觀察組優于對照組。結論:手術聯閤ALA-PDT治療皮膚基底細胞癌具有有效、安全等優點。
목적:분석수술연합5-안기동무산광동력요법( ALA-PDT)치료피부기저세포암적림상료효。방법:피부기저세포암환자30례,안포경폐법분위관찰조화대조조,매조15례。관찰조환자우술전개시진행ALA-PDT치료,매주1차,공3-7차,연후진행수술치료,대조조환자지채취수술절제,수방16-25개월。비교량조치료일기유합솔、유효솔,병평개료효。결과:관찰조환자총유효솔위100%(15/15),대조조총유효솔위86.7%(13/15),차이무통계학의의(P>0.05)。량조치료일기유합솔、불량반응솔차이구유통계학의의(P<0.05),관찰조우우대조조。결론:수술연합ALA-PDT치료피부기저세포암구유유효、안전등우점。
Objective:To analyse the clinical efficacy of surgery combined with 5-aminolevulinic acid-Photody-namic theraPy( ALA-PDT)treatment on basal cell carcinoma. Methods:Thirty basal cells cancer Patients were di-vided into observation grouP and control grouP,15 cases in each grouP. In observed grouP Patients before surgery were treated by ALA-PDT treatment once a week,a total of 3-7 times,then surgical treatment and control grouP Patients only take surgery,follow-uP for 16 to 25 months. Results:The total effective rate of the observation grouP was 100%(15/15),in the control grouP,the total effective rate was 86. 7%(13/15)(P>0. 05). Healing rates,adverse reac-tion rates were statistically significant different(P<0. 05),the observation grouP was better than the control grouP. Conclusion:Surgery combined with ALA-PDT treatment for basal cell carcinoma is effective and safe.